Literature DB >> 18504926

Gamma knife radiosurgery for malignant melanoma brain metastases.

David Mathieu1, Douglas Kondziolka, Patrick B Cooper, John C Flickinger, Ajay Niranjan, Sanjiv Agarwala, John Kirkwood, L Dade Lunsford.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18504926

Source DB:  PubMed          Journal:  Clin Neurosurg        ISSN： 0069-4827


× No keyword cloud information.
  16 in total

1.  Melanoma brain metastases: is it time to reassess the bias?

Authors:  Jaclyn C Flanigan; Lucia B Jilaveanu; Mark Faries; Mario Sznol; Stephan Ariyan; James B Yu; Jonathan P S Knisely; Veronica L Chiang; Harriet M Kluger
Journal:  Curr Probl Cancer       Date:  2011 Jul-Aug       Impact factor: 3.187

Review 2.  The Treatment of Melanoma Brain Metastases.

Authors:  Nour Kibbi; Harriet Kluger
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

3.  Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.

Authors:  Sarah B Goldberg; Scott N Gettinger; Amit Mahajan; Anne C Chiang; Roy S Herbst; Mario Sznol; Apostolos John Tsiouris; Justine Cohen; Alexander Vortmeyer; Lucia Jilaveanu; James Yu; Upendra Hegde; Stephanie Speaker; Matthew Madura; Amanda Ralabate; Angel Rivera; Elin Rowen; Heather Gerrish; Xiaopan Yao; Veronica Chiang; Harriet M Kluger
Journal:  Lancet Oncol       Date:  2016-06-03       Impact factor: 41.316

Review 4.  Expected Paradigm Shift in Brain Metastases Therapy-Immune Checkpoint Inhibitors.

Authors:  Vishal Jindal; Sorab Gupta
Journal:  Mol Neurobiol       Date:  2018-01-30       Impact factor: 5.590

Review 5.  Glioma and glioblastoma - how much do we (not) know?

Authors:  Ivana Jovčevska; Nina Kočevar; Radovan Komel
Journal:  Mol Clin Oncol       Date:  2013-08-26

6.  A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer.

Authors:  Muhammad Zubair Afzal; Konstantin Dragnev; Keisuke Shirai
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

7.  The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma.

Authors:  Anna Wilkins; Andrew Furness; Richard W Corbett; Adam Bloomfield; Nuria Porta; Stephen Morris; Zohra Ali; James Larkin; Kevin Harrington
Journal:  Br J Cancer       Date:  2015-10-20       Impact factor: 7.640

Review 8.  Systemic Immunotherapy for the Treatment of Brain Metastases.

Authors:  Justine V Cohen; Harriet M Kluger
Journal:  Front Oncol       Date:  2016-03-09       Impact factor: 6.244

Review 9.  Management of intracranial melanomas in the era of precision medicine.

Authors:  Grace J Young; Wenya Linda Bi; Winona W Wu; Tanner M Johanns; Gavin P Dunn; Ian F Dunn
Journal:  Oncotarget       Date:  2017-07-13

10.  Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.

Authors:  Shelly Lwu; Pablo Goetz; Eric Monsalves; Mandana Aryaee; Julius Ebinu; Norm Laperriere; Cynthia Menard; Caroline Chung; Barbara-Ann Millar; Abhaya V Kulkarni; Mark Bernstein; Gelareh Zadeh
Journal:  Oncol Rep       Date:  2012-11-14       Impact factor: 3.906
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.